Sublingual misoprostol versus intravenous oxytocin in the management of postpartum hemorrhage

Tehran University Medical Journal

Volumn 67, Issue 8, 2009, Pages 556-561

  Beigi, A ^a   Tabarestani, H ^a   Moini, A ^a   Zarrinkoub, F ^a   Kazempour, M ^a   Hadian Amree, A ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Labor; Misoprostol; Oxytocin

Indexed keywords

HEMOGLOBIN; MISOPROSTOL; OXYTOCIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRAN; LABOR STAGE 3; MAJOR CLINICAL STUDY; NULLIPARA; POSTPARTUM HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL; SHIVERING;

EID: 77953370565     PISSN: 16831764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Chapter 35: Postpartum hemorrhage. Williams's Obstetrics 22nd ed. 2008; Pages 823-39.
2. Chelmow D. Postpartum haemorrhage: prevention. Clin Evid (Online) 2008; pii: 1410.
3. Gülmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for prevention of postpartum haemorrhage. Cochrane Database Syst Rev 2004; (1):CD000494.
4. Prata N, Hamza S, Gypson R, Nada K, Vahidnia F, Potts M. Misoprostol and active management of the third stage of labor. Int J Gynaecol Obstet 2006; 94(2):149-55.
5. Tsu VD, Shane B. New and underutilized technologies to reduce maternal mortality: call to action from a Bellagio workshop. Int J Gynaecol Obstet 2004; 85 Suppl 1:S83-93.
6. Goudar SS, Chakraborty H, Edlavitch SA, Naik VA, Bellad MB, Patted SS, et al. Variation in the postpartum hemorrhage rate in a clinical trial of oral misoprostol. J Matern Fetal Neonatal Med 2008; 21(8):559-64.
7. Patted SS, Goudar SS, Naik VA, Bellad MB, Edlavitch SA, Kodkany BS, et al. Side effects of oral misoprostol for the prevention of postpartum hemorrhage: results of a communitybased randomised controlled trial in rural India. J Matern Fetal Neonatal Med 2009; 22(1):24-8.
8. Villar J, Gülmezoglu AM, Hofmeyr GJ, Forna F. Systematic review of randomized controlled trials of misoprostol to prevent postpartum hemorrhage. Obstet Gynecol 2002; 100(6):1301-12.
9. Baskett TF, Persad VL, Clough HJ, Young DC. Misoprostol versus oxytocin for the reduction of postpartum blood loss. Int J Gynaecol Obstet 2007; 97(1):2-5.
10. Nasr A, Shahin AY, Elsamman AM, Zakherah MS, Shaaban OM. Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage. Int J Gynaecol Obstet 2009; 105(3):244-7.
11. Zuberi NF, Durocher J, Sikander R, Baber N, Blum J, Walraven G. Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan. BMC Pregnancy Childbirth 2008; 8:40.
12. Lam H, Tang OS, Lee CP, Ho PC. A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor. Acta Obstet Gynecol Scand 2004; 83(7):647-50.
13. Ng PS, Lai CY, Sahota DS, Yuen PM. A double-blind randomized controlled trial of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor. Gynecol Obstet Invest 2007; 63(1):55-60.
14. Vimala N, Mittal S, Kumar S. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section. Int J Gynaecol Obstet 2006; 92(2):106-10.
15. Gülmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2007; (3):CD000494.